Spring Co-op/R&D Engineering Services jobs in United States
cer-icon
Apply on Employer Site
company-logo

GSK · 2 months ago

Spring Co-op/R&D Engineering Services

GSK is a global biopharma company dedicated to uniting science, technology, and talent to advance healthcare. The Spring Co-op in R&D Engineering Services involves supporting engineering disciplines and initiatives in a research and development facility, focusing on daily operations and capital projects.

BiotechnologyHealth CarePharmaceutical
check
H1B Sponsor Likelynote

Responsibilities

Support daily operations, capital projects, and engineering standards implementation and execution

Qualification

Engineering degreeData analyticsMicrosoft Office SuiteSafety backgroundManufacturing background

Required

Pursuing a BS or MS degree in an Engineering field (Mechanical, Chemical, or Electrical)
Proficiency in Microsoft Office Suite (Excel, PowerPoint, Word)
Must be able to work full-time (35-40 hours/week) throughout the 6 month co-op (March ~ September 2026)
Must have an active student status and/or within 12 months post-graduation from a BS or MS degree program. Post-doctoral candidates are not-eligible
Must successfully pass a drug screen and background check prior to assignment target start date

Preferred

Safety and/or Manufacturing background is preferred
Working knowledge of data analytics (PowerBI)

Benefits

Relocation stipend
Competitive hourly pay rate
Medical benefits
Fringe benefits
Overtime pay

Company

We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia

H1B Sponsorship

GSK has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (45)
2024 (56)
2023 (54)
2022 (53)
2021 (54)
2020 (72)

Funding

Current Stage
Public Company
Total Funding
$25.51M
Key Investors
CARB-X
2021-03-02Grant· $18M
2020-09-23Grant· $7.51M
1978-01-13IPO

Leadership Team

leader-logo
Julie Brown
CFO
linkedin
leader-logo
Mike Elmore
SVP & Chief Information Security Officer, GSK
linkedin
Company data provided by crunchbase